BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34374210)

  • 1. GATA2 rs2335052 and GATA2 rs78245253 single-nucleotide polymorphisms in Chinese patients with acute myelocytic leukemia.
    Fang F; Xu J; Kang Y; Ren H; Muyey DM; Chen X; Tan Y; Xu Z; Wang H
    Int J Lab Hematol; 2021 Dec; 43(6):1491-1500. PubMed ID: 34374210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GATA2 rs2335052 Polymorphism Predicts the Survival of Patients with Colorectal Cancer.
    Liu X; Jiang B; Wang A; Di J; Wang Z; Chen L; Su X
    PLoS One; 2015; 10(8):e0136020. PubMed ID: 26287967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia.
    Tien FM; Hou HA; Tsai CH; Tang JL; Chiu YC; Chen CY; Kuo YY; Tseng MH; Peng YL; Liu MC; Liu CW; Liao XW; Lin LI; Lin CT; Wu SJ; Ko BS; Hsu SC; Huang SY; Yao M; Chou WC; Tien HF
    Blood Cancer J; 2018 Aug; 8(9):87. PubMed ID: 30190467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms of histone methyltransferase SETD2 predicts prognosis and chemotherapy response in Chinese acute myeloid leukemia patients.
    Wang S; Yuan X; Liu Y; Zhu K; Chen P; Yan H; Zhang D; Li X; Zeng H; Zhao X; Chen X; Zhou G; Cao S
    J Transl Med; 2019 Mar; 17(1):101. PubMed ID: 30922329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution.
    Hou HA; Lin YC; Kuo YY; Chou WC; Lin CC; Liu CY; Chen CY; Lin LI; Tseng MH; Huang CF; Chiang YC; Liu MC; Liu CW; Tang JL; Yao M; Huang SY; Ko BS; Hsu SC; Wu SJ; Tsay W; Chen YC; Tien HF
    Ann Hematol; 2015 Feb; 94(2):211-21. PubMed ID: 25241285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation of GATA2 and its impact on normal karyotype acute myeloid leukemia.
    Celton M; Forest A; Gosse G; Lemieux S; Hebert J; Sauvageau G; Wilhelm BT
    Leukemia; 2014 Aug; 28(8):1617-26. PubMed ID: 24514424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between DNA methyltransferases 3B gene polymorphisms and the susceptibility to acute myeloid leukemia in Chinese Han population.
    Zheng Q; Zeng TT; Chen J; Liu H; Zhang H; Su J
    PLoS One; 2013; 8(9):e74626. PubMed ID: 24069326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of genetic polymorphisms in genes involved in Ara-C and dNTP metabolism pathway with chemosensitivity and prognosis of adult acute myeloid leukemia (AML).
    Zhu KW; Chen P; Zhang DY; Yan H; Liu H; Cen LN; Liu YL; Cao S; Zhou G; Zeng H; Chen SP; Zhao XL; Chen XP
    J Transl Med; 2018 Apr; 16(1):90. PubMed ID: 29631596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of DNMT3A genetic polymorphisms as outcome predictors in AML patients.
    Yuan XQ; Zhang DY; Yan H; Yang YL; Zhu KW; Chen YH; Li X; Yin JY; Li XL; Zeng H; Chen XP
    Oncotarget; 2016 Sep; 7(37):60555-60574. PubMed ID: 27528035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms at microRNA binding sites of Ara-C and anthracyclines-metabolic pathway genes are associated with outcome of acute myeloid leukemia patients.
    Cao HX; Miao CF; Yan L; Tang P; Zhang LR; Sun L
    J Transl Med; 2017 Nov; 15(1):235. PubMed ID: 29141648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA GAS5 polymorphism predicts a poor prognosis of acute myeloid leukemia in Chinese patients via affecting hematopoietic reconstitution.
    Yan H; Zhang DY; Li X; Yuan XQ; Yang YL; Zhu KW; Zeng H; Li XL; Cao S; Zhou HH; Zhang W; Chen XP
    Leuk Lymphoma; 2017 Aug; 58(8):1948-1957. PubMed ID: 27951730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia.
    Greif PA; Dufour A; Konstandin NP; Ksienzyk B; Zellmeier E; Tizazu B; Sturm J; Benthaus T; Herold T; Yaghmaie M; Dörge P; Hopfner KP; Hauser A; Graf A; Krebs S; Blum H; Kakadia PM; Schneider S; Hoster E; Schneider F; Stanulla M; Braess J; Sauerland MC; Berdel WE; Büchner T; Woermann BJ; Hiddemann W; Spiekermann K; Bohlander SK
    Blood; 2012 Jul; 120(2):395-403. PubMed ID: 22649106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing.
    Wang B; Liu Y; Hou G; Wang L; Lv N; Xu Y; Xu Y; Wang X; Xuan Z; Jing Y; Li H; Jin X; Deng A; Wang L; Gao X; Dou L; Liang J; Chen C; Li Y; Yu L
    Oncotarget; 2016 May; 7(22):32065-78. PubMed ID: 27062340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High GATA2 expression is a poor prognostic marker in pediatric acute myeloid leukemia.
    Luesink M; Hollink IH; van der Velden VH; Knops RH; Boezeman JB; de Haas V; Trka J; Baruchel A; Reinhardt D; van der Reijden BA; van den Heuvel-Eibrink MM; Zwaan CM; Jansen JH
    Blood; 2012 Sep; 120(10):2064-75. PubMed ID: 22786876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GATA Factor-Dependent Positive-Feedback Circuit in Acute Myeloid Leukemia Cells.
    Katsumura KR; Ong IM; DeVilbiss AW; Sanalkumar R; Bresnick EH
    Cell Rep; 2016 Aug; 16(9):2428-41. PubMed ID: 27545880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allele-specific expression of GATA2 due to epigenetic dysregulation in CEBPA double-mutant AML.
    Mulet-Lazaro R; van Herk S; Erpelinck C; Bindels E; Sanders MA; Vermeulen C; Renkens I; Valk P; Melnick AM; de Ridder J; Rehli M; Gebhard C; Delwel R; Wouters BJ
    Blood; 2021 Jul; 138(2):160-177. PubMed ID: 33831168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis.
    Mosrati MA; Willander K; Falk IJ; Hermanson M; Höglund M; Stockelberg D; Wei Y; Lotfi K; Söderkvist P
    Oncotarget; 2015 Sep; 6(28):25109-20. PubMed ID: 26298771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GATA2 gene analysis in several forms of hematological malignancies including familial aggregations.
    Hamadou WS; Mani R; Besbes S; Bourdon V; Youssef YB; Eisinger F; Mari V; Gesta P; Dreyfus H; Bonadona V; Dugast C; Zattara H; Faivre L; Noguchi T; Khélif A; Sobol H; Soua Z
    Ann Hematol; 2017 Oct; 96(10):1635-1639. PubMed ID: 28752392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of measurable residual disease may better predict outcomes than mutations based on next-generation sequencing in acute myeloid leukaemia with biallelic mutations of CEBPA.
    Wang J; Lu R; Wu Y; Jia J; Gong L; Liu X; Lu S; Wang Y; Yan C; Liu K; Zhang X; Xu L; Jiang Q; Zhao X; Shi H; Lai Y; Huang X; Ruan G; Jiang H
    Br J Haematol; 2020 Aug; 190(4):533-544. PubMed ID: 32090321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association study of GATA-2 transcription factor gene (GATA2) polymorphism and Parkinson's disease.
    Kurzawski M; Białecka M; Sławek J; Kłodowska-Duda G; Droździk M
    Parkinsonism Relat Disord; 2010 May; 16(4):284-7. PubMed ID: 19864173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.